Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Bullboard Posts
Post by MartialArtson Jun 14, 2018 11:35am
208 Views
Post# 28172118

Won't 2019 revenues be

Won't 2019 revenues be
I'm trying to undertstand the math of analysts. I understand the BUY and STRONG BUY rating but the revenues seem understated for 2019?

According to all the filings, estimates etc, Aphria will be producing 250,000 KG per year in less than a year.

250,000 KG = 250,000,000 grams 
= $750M/year at $3 per gram
= $1B/year at $4 per gram
= $1.25B/year at $5 per gram

So why are the revenues by analysts just $146-286M/year for 2019?  Are they using old numbers?
Bullboard Posts